About Envisage
Envisage is a quarterly magazine devoted to covering the trends and issues that shape the development of medicines. Our primary objective is to facilitate discussion by presenting the ideas and insight of thought leaders and practitioners. We strive for an objective approach by including perspectives from industry, academia and government, as well as the voices of the everyday clinicians who ultimately link drug development to patient care.
Publisher
Matt Fleming
Associate Publisher
Heidi M. Hjerpe
Editor
Adam Istas
Managing Editor
Sarah Stone Wunder
Art Director
Tiffany Mehnert
Director of Production and Operations
Heather L. Slattery
Research Editor
Sara Robertson
Imagination Publishing
600 West Fulton St., Ste. 600
Chicago, Illinois USA 60661
phone 312.887.1000
fax 312.887.1003
President
James E. Meyers
Executive Vice President, New Business Development
Rebecca Rolfes
Executive Vice President, Design Director
Douglas Kelly
Senior Vice President, Finance & Human Resources
Janet Ortaggio
Vice President, Group Publishing
Joe Stella
Vice President, ROI & Measurement
Richard Baumer
Vice President, Marketing
Michelle O’Hagan
© 2008 Imagination Publishing. All Rights Reserved. No part of this publication may be reprinted or reproduced without written permission from the editor. Although every precaution has been taken in the preparation of this magazine, Imagination Publishing assumes no responsibility for errors or omissions.
Envisage is underwritten by Quintiles Transnational.
Web Exclusives
- Turning the Corner
-
After decades of neglect, leading to a rapid increase in incidence, tuberculosis started gaining attention from industrialized nations over the past 10 years. With this new focus, TB’s incidence has started to decrease—but barely.
- A Weighty Problem
-
As pharmaceutical companies search for a blockbuster fat-fighting drug, the biggest battle is against side effects.